{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Hormesis", "Neurodegenerative disorders", "Neurological disorders", "Phytochemicals"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35953850", "DateRevised": {"Year": "2022", "Month": "08", "Day": "15"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "11"}], "Language": ["eng"], "ELocationID": ["36", "10.1186/s12979-022-00292-x"], "Journal": {"ISSN": "1742-4933", "JournalIssue": {"Volume": "19", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Aug", "Day": "11"}}, "Title": "Immunity & ageing : I & A", "ISOAbbreviation": "Immun Ageing"}, "ArticleTitle": "Neurohormetic phytochemicals in the pathogenesis of neurodegenerative diseases.", "Pagination": {"StartPage": "36", "MedlinePgn": "36"}, "Abstract": {"AbstractText": ["The world population is progressively ageing, assuming an enormous social and health challenge. As the world ages, neurodegenerative diseases are on the rise. Regarding the progressive nature of these diseases, none of the neurodegenerative diseases are curable at date, and the existing treatments can only help relieve the symptoms or slow the progression. Recently, hormesis has increased attention in the treatment of age-related neurodegenerative diseases. The concept of hormesis refers to a biphasic dose-response phenomenon, where low levels of the drug or stress exert protective of beneficial effects and high doses deleterious or toxic effects. Neurohormesis, as the adaptive aspect of hormetic dose responses in neurons, has been shown to slow the onset of neurodegenerative diseases and reduce the damages caused by aging, stroke, and traumatic brain injury. Hormesis was also observed to modulate anxiety, stress, pain, and the severity of seizure. Thus, neurohormesis can be considered as a potentially innovative approach in the treatment of neurodegenerative and other neurologic disorders. Herbal medicinal products and supplements are often considered health resources with many applications. The hormesis phenomenon in medicinal plants is valuable and several studies have shown that hormetic mechanisms of bioactive compounds can prevent or ameliorate the neurodegenerative pathogenesis in animal models of Alzheimer's and Parkinson's diseases. Moreover, the hormesis activity of phytochemicals has been evaluated in other neurological disorders such as Autism and Huntington's disease. In this review, the neurohormetic dose-response concept and the possible underlying neuroprotection mechanisms are discussed. Different neurohormetic phytochemicals used for the better management of neurodegenerative diseases, the rationale for using them, and the key findings of their studies are also reviewed."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Research Center, Department of Internal Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Sahebnasagh", "ForeName": "Adeleh", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Traditional Pharmacy, School of Pharmacy, Birjand University of Medical Sciences, Birjand, Iran."}, {"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran."}], "LastName": "Eghbali", "ForeName": "Samira", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran."}], "LastName": "Saghafi", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands-IUNICS, and Health Research Institute of Balearic Islands (IdISBa), Palma de Mallorca, Spain."}, {"Identifier": [], "Affiliation": "CIBER Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain."}], "LastName": "Sureda", "ForeName": "Antoni", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, School of Pharmacy, Medical Toxicology and Drug Abuse Research Center, Birjand University of Medical Sciences, Birjand, Iran. avanr91@gmail.com."}], "LastName": "Avan", "ForeName": "Razieh", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Immun Ageing", "NlmUniqueID": "101235427", "ISSNLinking": "1742-4933"}, "CoiStatement": "The authors declared no potential competing of interest concerning the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Brown RC, Lockwood AH, Sonawane BR. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect. 2005;113(9):1250\u20131256. doi: 10.1289/ehp.7567.", "ArticleIdList": ["10.1289/ehp.7567", "PMC1280411", "16140637"]}, {"Citation": "Dur\u00e3es F, Pinto M, Sousa E. Old drugs as new treatments for neurodegenerative diseases. Pharmaceuticals. 2018;11(2):44. doi: 10.3390/ph11020044.", "ArticleIdList": ["10.3390/ph11020044", "PMC6027455", "29751602"]}, {"Citation": "Martin B, Ji S, White CM, Maudsley S, Mattson MP. Dietary energy intake, hormesis, and health. Hormesis: Springer; 2010. pp. 123\u2013137."}, {"Citation": "Calabrese EJ. Neuroscience and hormesis: overview and general findings. Crit Rev Toxicol. 2008;38(4):249\u2013252. doi: 10.1080/10408440801981957.", "ArticleIdList": ["10.1080/10408440801981957", "18432418"]}, {"Citation": "Zhang C, Li C, Chen S, Li Z, Ma L, Jia X, et al. Hormetic effect of panaxatriol saponins confers neuroprotection in PC12 cells and zebrafish through PI3K/AKT/mTOR and AMPK/SIRT1/FOXO3 pathways. Sci Rep. 2017;7(1):1\u201312. doi: 10.1038/s41598-016-0028-x.", "ArticleIdList": ["10.1038/s41598-016-0028-x", "PMC5253660", "28112228"]}, {"Citation": "Doss M. Linear no-threshold model vs. radiation hormesis. Dose-response. 2013;11(4) dose-response. 13-005. Doss.", "ArticleIdList": ["PMC3834742", "24298226"]}, {"Citation": "Calabrese EJ, Calabrese V, Giordano J. The role of hormesis in the functional performance and protection of neural systems. Brain circulation. 2017;3(1):1. doi: 10.4103/2394-8108.203257.", "ArticleIdList": ["10.4103/2394-8108.203257", "PMC6126232", "30276298"]}, {"Citation": "Arendash GW. Transcranial electromagnetic treatment against Alzheimer's disease: why it has the potential to trump Alzheimer's disease drug development. J Alzheimers Dis. 2012;32(2):243\u2013266. doi: 10.3233/JAD-2012-120943.", "ArticleIdList": ["10.3233/JAD-2012-120943", "22810103"]}, {"Citation": "Calabrese V, Santoro A, Trovato Salinaro A, Modafferi S, Scuto M, Albouchi F, et al. Hormetic approaches to the treatment of Parkinson's disease: perspectives and possibilities. J Neurosci Res. 2018;96(10):1641\u20131662. doi: 10.1002/jnr.24244.", "ArticleIdList": ["10.1002/jnr.24244", "30098077"]}, {"Citation": "Eghbali S, Askari SF, Avan R, Sahebkar A. Therapeutic effects of Punica granatum (pomegranate): an updated review of clinical trials. Journal of Nutrition and Metabolism. 2021;2021.", "ArticleIdList": ["PMC8595036", "34796029"]}, {"Citation": "Darvishpour S, Avan R, Azadbakht M, Maham M, Akbari J, Janbabaei G, et al. Malus domestica reduces chemotherapy-induced nausea and vomiting: a randomized double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences. 2021;26.", "ArticleIdList": ["PMC8548888", "34759989"]}, {"Citation": "Ma\u0142kowski E, Sitko K, Szopi\u0144ski M, Giero\u0144 \u017b, Pogrzeba M, Kalaji HM, et al. Hormesis in plants: the role of oxidative stress, auxins and photosynthesis in corn treated with cd or Pb. Int J Mol Sci. 2020;21(6):2099. doi: 10.3390/ijms21062099.", "ArticleIdList": ["10.3390/ijms21062099", "PMC7139973", "32204316"]}, {"Citation": "de Andrade Teles RB, Diniz TC, Costa Pinto TC, de Oliveira J\u00fanior RG, Gama e Silva M, de Lavor \u00c9M, et al. Flavonoids as therapeutic agents in Alzheimer\u2019s and Parkinson\u2019s diseases: A systematic review of preclinical evidences. Oxidative Med Cell Longev. 2018.", "ArticleIdList": ["PMC5971291", "29861833"]}, {"Citation": "Salinaro AT, Pennisi M, Di Paola R, Scuto M, Crupi R, Cambria MT, et al. Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer\u2019s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms. Immun Ageing. 2018;15(1):1\u20138. doi: 10.1186/s12979-017-0112-5.", "ArticleIdList": ["10.1186/s12979-017-0112-5", "PMC5813410", "29456585"]}, {"Citation": "Csaba G. Hormesis and immunity: a review. Acta Microbiol Immunol Hung. 2019;66(2):155\u2013168. doi: 10.1556/030.65.2018.036.", "ArticleIdList": ["10.1556/030.65.2018.036", "30014704"]}, {"Citation": "Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson MP. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal. 2010;13(11):1763\u20131811. doi: 10.1089/ars.2009.3074.", "ArticleIdList": ["10.1089/ars.2009.3074", "PMC2966482", "20446769"]}, {"Citation": "Mattson MP, Son TG, Camandola S. Mechanisms of action and therapeutic potential of neurohormetic phytochemicals. Dose-response. 2007;5(3) dose-response. 07-004. Mattson.", "ArticleIdList": ["PMC2477698", "18648607"]}, {"Citation": "Gezer C. Stress response of dietary phytochemicals in a hormetic manner for health and longevity. Gene expression and Regulation in Mammalian Cells-Transcription Toward the Establishment of Novel Therapeutics. 2018."}, {"Citation": "Farooqui AA. Phytochemicals, Signal transduction, and neurological disorders. Springer Science & Business Media; 2012."}, {"Citation": "Mattson MP, Cheng A. Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci. 2006;29(11):632\u2013639. doi: 10.1016/j.tins.2006.09.001.", "ArticleIdList": ["10.1016/j.tins.2006.09.001", "17000014"]}, {"Citation": "Calabrese V, Cornelius C, Dinkova-Kostova AT, Iavicoli I, Di Paola R, Koverech A, et al. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2012;1822(5):753\u2013783. doi: 10.1016/j.bbadis.2011.11.002.", "ArticleIdList": ["10.1016/j.bbadis.2011.11.002", "22108204"]}, {"Citation": "Falchetti R, Fuggetta MP, Lanzilli G, Tricarico M, Ravagnan G. Effects of resveratrol on human immune cell function. Life Sci. 2001;70(1):81\u201396. doi: 10.1016/S0024-3205(01)01367-4.", "ArticleIdList": ["10.1016/S0024-3205(01)01367-4", "11764009"]}, {"Citation": "Son TG, Camandola S, Mattson MP. Hormetic dietary phytochemicals. NeuroMolecular Med. 2008;10(4):236\u2013246. doi: 10.1007/s12017-008-8037-y.", "ArticleIdList": ["10.1007/s12017-008-8037-y", "PMC2635914", "18543123"]}, {"Citation": "Jagetia GC, Aggarwal BB. \u201cSpicing up\u201d of the immune system by curcumin. J Clin Immunol. 2007;27(1):19\u201335. doi: 10.1007/s10875-006-9066-7.", "ArticleIdList": ["10.1007/s10875-006-9066-7", "17211725"]}, {"Citation": "Gao X, Kuo J, Jiang H, Deeb D, Liu Y, Divine G, et al. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol. 2004;68(1):51\u201361. doi: 10.1016/j.bcp.2004.03.015.", "ArticleIdList": ["10.1016/j.bcp.2004.03.015", "15183117"]}, {"Citation": "Juge N, Mithen R, Traka M. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci. 2007;64(9):1105\u20131127. doi: 10.1007/s00018-007-6484-5.", "ArticleIdList": ["10.1007/s00018-007-6484-5", "17396224"]}, {"Citation": "Gonz\u00e1lez-Reyes S, Guzm\u00e1n-Beltr\u00e1n S, Medina-Campos ON, Pedraza-Chaverri J. Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats. Oxidative Med Cell Longev. 2013;2013.", "ArticleIdList": ["PMC3885319", "24454990"]}, {"Citation": "Lee-Hilz YY, Boerboom A-MJ, Westphal AH, van Berkel WJ, Aarts JM, Rietjens IM. Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression. Chem Res Toxicol. 2006;19(11):1499\u20131505. doi: 10.1021/tx060157q.", "ArticleIdList": ["10.1021/tx060157q", "17112238"]}, {"Citation": "Wu C, Hsu M, Hsieh C, Lin J, Lai P, Wung B. Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci. 2006;78(25):2889\u20132897. doi: 10.1016/j.lfs.2005.11.013.", "ArticleIdList": ["10.1016/j.lfs.2005.11.013", "16378625"]}, {"Citation": "Vincent AM, Kato K, McLean LL, Soules ME, Feldman EL. Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms. Antioxid Redox Signal. 2009;11(3):425\u2013438. doi: 10.1089/ars.2008.2235.", "ArticleIdList": ["10.1089/ars.2008.2235", "PMC2933574", "19072199"]}, {"Citation": "Mattson MP. Hormesis defined. Ageing Res Rev. 2008;7(1):1\u20137. doi: 10.1016/j.arr.2007.08.007.", "ArticleIdList": ["10.1016/j.arr.2007.08.007", "PMC2248601", "18162444"]}, {"Citation": "Robb EL, Page MM, Wiens BE, Stuart JA. Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive induction of MnSOD. Biochem Biophys Res Commun. 2008;367(2):406\u2013412. doi: 10.1016/j.bbrc.2007.12.138.", "ArticleIdList": ["10.1016/j.bbrc.2007.12.138", "18167310"]}, {"Citation": "Mattson MP. Awareness of hormesis will enhance future research in basic and applied neuroscience. Crit Rev Toxicol. 2008;38(7):633\u2013639. doi: 10.1080/10408440802026406.", "ArticleIdList": ["10.1080/10408440802026406", "PMC2612999", "18709572"]}, {"Citation": "Farooqui T, Farooqui AA. Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev. 2009;130(4):203\u2013215. doi: 10.1016/j.mad.2008.11.006.", "ArticleIdList": ["10.1016/j.mad.2008.11.006", "19071157"]}, {"Citation": "Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9(7):a028035. doi: 10.1101/cshperspect.a028035.", "ArticleIdList": ["10.1101/cshperspect.a028035", "PMC5495060", "28062563"]}, {"Citation": "Arumugam TV, Gleichmann M, Tang S-C, Mattson MP. Hormesis/preconditioning mechanisms, the nervous system and aging. Ageing Res Rev. 2006;5(2):165\u2013178. doi: 10.1016/j.arr.2006.03.003.", "ArticleIdList": ["10.1016/j.arr.2006.03.003", "16682262"]}, {"Citation": "Homma S, Jin X, Wang G, Tu N, Min J, Yanasak N, et al. Demyelination, astrogliosis, and accumulation of ubiquitinated proteins, hallmarks of CNS disease in hsf1-deficient mice. J Neurosci. 2007;27(30):7974\u20137986. doi: 10.1523/JNEUROSCI.0006-07.2007.", "ArticleIdList": ["10.1523/JNEUROSCI.0006-07.2007", "PMC6672719", "17652588"]}, {"Citation": "Ogino M, Ichimura M, Nakano N, Minami A, Kitagishi Y, Matsuda S. Roles of PTEN with DNA repair in Parkinson\u2019s disease. Int J Mol Sci. 2016;17(6):954. doi: 10.3390/ijms17060954.", "ArticleIdList": ["10.3390/ijms17060954", "PMC4926487", "27314344"]}, {"Citation": "Eghbaliferiz S, Iranshahi M. Prooxidant activity of polyphenols, flavonoids, anthocyanins and carotenoids: updated review of mechanisms and catalyzing metals. Phytother Res. 2016;30(9):1379\u20131391. doi: 10.1002/ptr.5643.", "ArticleIdList": ["10.1002/ptr.5643", "27241122"]}, {"Citation": "Leandro GS, Sykora P, Bohr VA. The impact of base excision DNA repair in age-related neurodegenerative diseases. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2015;776:31\u201339. doi: 10.1016/j.mrfmmm.2014.12.011.", "ArticleIdList": ["10.1016/j.mrfmmm.2014.12.011", "PMC5576886", "26255938"]}, {"Citation": "Jeppesen DK, Bohr VA, Stevnsner T. DNA repair deficiency in neurodegeneration. Prog Neurobiol. 2011;94(2):166\u2013200. doi: 10.1016/j.pneurobio.2011.04.013.", "ArticleIdList": ["10.1016/j.pneurobio.2011.04.013", "PMC3123739", "21550379"]}, {"Citation": "Wang G. Hormesis, cell death, and regenerative medicine for neurodegenerative diseases. Dose-response. 2013;11(2):dose-response. 12-019. Wang. .", "ArticleIdList": ["PMC3682200", "23930104"]}, {"Citation": "Yuyun X, Jinjun Q, Minfang X, Jing Q, Juan X, Rui M, et al. Effects of low concentrations of rotenone upon mitohormesis in SH-SY5Y cells. Dose-response. 2013;11(2):dose-response. 12-005. Gao. .", "ArticleIdList": ["PMC3682202", "23930106"]}, {"Citation": "Zhu X, Wei Y, Yang B, Yin X, Guo X. The mitohormetic response as part of the cytoprotection mechanism of berberine. Mol Med. 2020;26(1):1\u20136. doi: 10.1186/s10020-020-0136-8.", "ArticleIdList": ["10.1186/s10020-020-0136-8", "PMC6979287", "31973689"]}, {"Citation": "Singh N, Sharma B. Toxicological effects of berberine and sanguinarine. Front Mol Biosci. 2018;5:21. doi: 10.3389/fmolb.2018.00021.", "ArticleIdList": ["10.3389/fmolb.2018.00021", "PMC5867333", "29616225"]}, {"Citation": "Asseburg H, Sch\u00e4fer C, M\u00fcller M, Hagl S, Pohland M, Berressem D, et al. Effects of grape skin extract on age-related mitochondrial dysfunction, memory and life span in C57BL/6J mice. NeuroMolecular Med. 2016;18(3):378\u2013395. doi: 10.1007/s12017-016-8428-4.", "ArticleIdList": ["10.1007/s12017-016-8428-4", "27455862"]}, {"Citation": "Yu T, Dohl J, Wang L, Chen Y, Gasier HG, Deuster PA. Curcumin Ameliorates Heat-Induced Injury through NADPH Oxidase\u2013Dependent Redox Signaling and Mitochondrial Preservation in C2C12 Myoblasts and Mouse Skeletal Muscle. J Nutr. 2020;150(9):2257\u20132267. doi: 10.1093/jn/nxaa201.", "ArticleIdList": ["10.1093/jn/nxaa201", "PMC7919340", "32692359"]}, {"Citation": "Banji OJ, Banji D, Ch K. Curcumin and hesperidin improve cognition by suppressing mitochondrial dysfunction and apoptosis induced by D-galactose in rat brain. Food Chem Toxicol. 2014;74:51\u201359. doi: 10.1016/j.fct.2014.08.020.", "ArticleIdList": ["10.1016/j.fct.2014.08.020", "25217884"]}, {"Citation": "Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6(1):1\u20134. doi: 10.1186/1472-6882-6-10.", "ArticleIdList": ["10.1186/1472-6882-6-10", "PMC1434783", "16545122"]}, {"Citation": "Govind P. Active principles and median lethal dose of Curcuma longa Linn. Internafional Research Journal of Pharmacy. 2011;2(5):239."}, {"Citation": "Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337\u2013342. doi: 10.1038/nature05354.", "ArticleIdList": ["10.1038/nature05354", "PMC4990206", "17086191"]}, {"Citation": "Shaito A, Posadino AM, Younes N, Hasan H, Halabi S, Alhababi D, et al. Potential adverse effects of resveratrol: a literature review. Int J Mol Sci. 2020;21(6):2084. doi: 10.3390/ijms21062084.", "ArticleIdList": ["10.3390/ijms21062084", "PMC7139620", "32197410"]}, {"Citation": "Mukherjee S, Dudley JI, Das DK. Dose-dependency of resveratrol in providing health benefits. Dose-response. 2010;8(4):dose-response. 09-015. Mukherjee. .", "ArticleIdList": ["PMC2990065", "21191486"]}, {"Citation": "Van Praag H, Lucero MJ, Yeo GW, Stecker K, Heivand N, Zhao C, et al. Plant-derived flavanol (\u2212) epicatechin enhances angiogenesis and retention of spatial memory in mice. J Neurosci. 2007;27(22):5869\u20135878. doi: 10.1523/JNEUROSCI.0914-07.2007.", "ArticleIdList": ["10.1523/JNEUROSCI.0914-07.2007", "PMC6672256", "17537957"]}, {"Citation": "Biasibetti R, Tramontina AC, Costa AP, Dutra MF, Quincozes-Santos A, Nardin P, et al. Green tea (\u2212) epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia. Behav Brain Res. 2013;236:186\u2013193. doi: 10.1016/j.bbr.2012.08.039.", "ArticleIdList": ["10.1016/j.bbr.2012.08.039", "22964138"]}, {"Citation": "Ramachandran B, Jayavelu S, Murhekar K, Rajkumar T. Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia. Toxicol Rep. 2016;3:336\u2013345. doi: 10.1016/j.toxrep.2016.03.001.", "ArticleIdList": ["10.1016/j.toxrep.2016.03.001", "PMC5615837", "28959554"]}, {"Citation": "Calabrese EJ, Tsatsakis A, Agathokleous E, Giordano J, Calabrese V. Does green tea induce hormesis? Dose-Response. 2020;18(3):1559325820936170. doi: 10.1177/1559325820936170.", "ArticleIdList": ["10.1177/1559325820936170", "PMC7364811", "32728352"]}, {"Citation": "Lambert JD, Kennett MJ, Sang S, Reuhl KR, Ju J, Yang CS. Hepatotoxicity of high oral dose (\u2212)-epigallocatechin-3-gallate in mice. Food Chem Toxicol. 2010;48(1):409\u2013416. doi: 10.1016/j.fct.2009.10.030.", "ArticleIdList": ["10.1016/j.fct.2009.10.030", "PMC2905152", "19883714"]}, {"Citation": "Zhao Y-N, Li W-F, Li F, Zhang Z, Dai Y-D, Xu A-L, et al. Resveratrol improves learning and memory in normally aged mice through microRNA-CREB pathway. Biochem Biophys Res Commun. 2013;435(4):597\u2013602. doi: 10.1016/j.bbrc.2013.05.025.", "ArticleIdList": ["10.1016/j.bbrc.2013.05.025", "23685142"]}, {"Citation": "Shibani F, Sahamsizadeh A, Fatemi I, Allahtavakoli M, Hasanshahi J, Rahmani M, et al. Effect of oleuropein on morphine-induced hippocampus neurotoxicity and memory impairments in rats. Naunyn Schmiedeberg's Arch Pharmacol. 2019;392(11):1383\u20131391. doi: 10.1007/s00210-019-01678-3.", "ArticleIdList": ["10.1007/s00210-019-01678-3", "31236657"]}, {"Citation": "Dekanski D, Mihailovi\u0107-Stanojevi\u0107 N, Gruji\u0107-Milanovi\u0107 J, Jovovi\u0107 \u0110, Miloradovi\u0107 Z. Effects of high dose olive leaf extract on the hemodynamic and oxidative stress parameters in normotensive and spontaneously hypertensive rats. J Serbian Chem Soc. 2014;79(9):1085\u20131097. doi: 10.2298/JSC140218030D.", "ArticleIdList": ["10.2298/JSC140218030D"]}, {"Citation": "Van Der Flier W, Van Den Heuvel D, Weverling-Rijnsburger A, Spilt A, Bollen E, Westendorp R, et al. Cognitive decline in AD and mild cognitive impairment is associated with global brain damage. Neurology. 2002;59(6):874\u2013879. doi: 10.1212/WNL.59.6.874.", "ArticleIdList": ["10.1212/WNL.59.6.874", "12297570"]}, {"Citation": "Askari SF, Avan R, Tayarani-Najaran Z, Sahebkar A, Eghbali S. Iranian Salvia species: a phytochemical and pharmacological update. Phytochemistry. 2021;183:112619. doi: 10.1016/j.phytochem.2020.112619.", "ArticleIdList": ["10.1016/j.phytochem.2020.112619", "33373790"]}, {"Citation": "Eggers C, Fujitani M, Kato R, Smid S. Novel cannabis flavonoid, cannflavin a displays both a hormetic and neuroprotective profile against amyloid \u03b2-mediated neurotoxicity in PC12 cells: comparison with geranylated flavonoids, mimulone and diplacone. Biochem Pharmacol. 2019;169:113609. doi: 10.1016/j.bcp.2019.08.011.", "ArticleIdList": ["10.1016/j.bcp.2019.08.011", "31437460"]}, {"Citation": "Joseph JA, Arendash G, Gordon M, Diamond D, Shukitt-Hale B, Morgan D, et al. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci. 2003;6(3):153\u2013162. doi: 10.1080/1028415031000111282.", "ArticleIdList": ["10.1080/1028415031000111282", "12793519"]}, {"Citation": "Kim H-J, Shin E-J, Lee B-H, Choi S-H, Jung S-W, Cho I-H, et al. Oral administration of gintonin attenuates cholinergic impairments by scopolamine, amyloid-\u03b2 protein, and mouse model of Alzheimer\u2019s disease. Mol Cell. 2015;38(9):796. doi: 10.14348/molcells.2015.0116.", "ArticleIdList": ["10.14348/molcells.2015.0116", "PMC4588723", "26255830"]}, {"Citation": "Nie L, Xia J, Li H, Zhang Z, Yang Y, Huang X, et al. Ginsenoside Rg1 ameliorates behavioral abnormalities and modulates the hippocampal proteomic change in triple transgenic mice of Alzheimer\u2019s disease. Oxidative Med Cell Longev. 2017;2017.", "ArticleIdList": ["PMC5674513", "29204248"]}, {"Citation": "Paik DJ, Lee CH. Review of cases of patient risk associated with ginseng abuse and misuse. Journal of ginseng research. 2015;39(2):89\u201393. doi: 10.1016/j.jgr.2014.11.005.", "ArticleIdList": ["10.1016/j.jgr.2014.11.005", "PMC4452531", "26045681"]}, {"Citation": "Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001;21(21):8370\u20138377. doi: 10.1523/JNEUROSCI.21-21-08370.2001.", "ArticleIdList": ["10.1523/JNEUROSCI.21-21-08370.2001", "PMC6762797", "11606625"]}, {"Citation": "Tiwari SK, Agarwal S, Seth B, Yadav A, Nair S, Bhatnagar P, et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer\u2019s disease model via canonical Wnt/\u03b2-catenin pathway. ACS Nano. 2014;8(1):76\u2013103. doi: 10.1021/nn405077y.", "ArticleIdList": ["10.1021/nn405077y", "24467380"]}, {"Citation": "Han YS, Zheng WH, Bastianetto S, Chabot JG, Quirion R. Neuroprotective effects of resveratrol against \u03b2-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol. 2004;141(6):997\u20131005. doi: 10.1038/sj.bjp.0705688.", "ArticleIdList": ["10.1038/sj.bjp.0705688", "PMC1574264", "15028639"]}, {"Citation": "Conte A, Pellegrini S, Tagliazucchi D. Synergistic protection of PC12 cells from \u03b2-amyloid toxicity by resveratrol and catechin. Brain Res Bull. 2003;62(1):29\u201338. doi: 10.1016/j.brainresbull.2003.08.001.", "ArticleIdList": ["10.1016/j.brainresbull.2003.08.001", "14596889"]}, {"Citation": "Haque AM, Hashimoto M, Katakura M, Hara Y, Shido O. Green tea catechins prevent cognitive deficits caused by A\u03b21\u201340 in rats. J Nutr Biochem. 2008;19(9):619\u2013626. doi: 10.1016/j.jnutbio.2007.08.008.", "ArticleIdList": ["10.1016/j.jnutbio.2007.08.008", "18280729"]}, {"Citation": "Kim J. Pre-clinical neuroprotective evidences and plausible mechanisms of Sulforaphane in Alzheimer\u2019s disease. Int J Mol Sci. 2021;22(6):2929. doi: 10.3390/ijms22062929.", "ArticleIdList": ["10.3390/ijms22062929", "PMC7999245", "33805772"]}, {"Citation": "Soca\u0142a K, Nieoczym D, Kowalczuk-Vasilev E, Wyska E, Wla\u017a P. Increased seizure susceptibility and other toxicity symptoms following acute sulforaphane treatment in mice. Toxicol Appl Pharmacol. 2017;326:43\u201353. doi: 10.1016/j.taap.2017.04.010.", "ArticleIdList": ["10.1016/j.taap.2017.04.010", "28412310"]}, {"Citation": "Esselun C, Theyssen E, Eckert GP. Effects of Urolithin a on mitochondrial parameters in a cellular model of early Alzheimer disease. Int J Mol Sci. 2021;22(15):8333. doi: 10.3390/ijms22158333.", "ArticleIdList": ["10.3390/ijms22158333", "PMC8347929", "34361099"]}, {"Citation": "Pedersen KF, Larsen JP, Tysnes O-B, Alves G. Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study. Neurology. 2017;88(8):767\u2013774. doi: 10.1212/WNL.0000000000003634.", "ArticleIdList": ["10.1212/WNL.0000000000003634", "28108638"]}, {"Citation": "Eghbaliferiz S, Farhadi F, Barreto GE, Majeed M, Sahebkar A. Effects of curcumin on neurological diseases: focus on astrocytes. Pharmacol Rep. 2020;72:769\u2013782. doi: 10.1007/s43440-020-00112-3.", "ArticleIdList": ["10.1007/s43440-020-00112-3", "32458309"]}, {"Citation": "Jin F, Wu Q, Lu Y-F, Gong Q-H, Shi J-S. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol. 2008;600(1-3):78\u201382. doi: 10.1016/j.ejphar.2008.10.005.", "ArticleIdList": ["10.1016/j.ejphar.2008.10.005", "18940189"]}, {"Citation": "Okawara M, Katsuki H, Kurimoto E, Shibata H, Kume T, Akaike A. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem Pharmacol. 2007;73(4):550\u2013560. doi: 10.1016/j.bcp.2006.11.003.", "ArticleIdList": ["10.1016/j.bcp.2006.11.003", "17147953"]}, {"Citation": "Gaballah HH, Zakaria SS, Elbatsh MM, Tahoon NM. Modulatory effects of resveratrol on endoplasmic reticulum stress-associated apoptosis and oxido-inflammatory markers in a rat model of rotenone-induced Parkinson's disease. Chem Biol Interact. 2016;251:10\u201316. doi: 10.1016/j.cbi.2016.03.023.", "ArticleIdList": ["10.1016/j.cbi.2016.03.023", "27016191"]}, {"Citation": "Levites Y, Amit T, Youdim MB, Mandel S. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (\u2212)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem. 2002;277(34):30574\u201330580. doi: 10.1074/jbc.M202832200.", "ArticleIdList": ["10.1074/jbc.M202832200", "12058035"]}, {"Citation": "Soliman AM, Fathalla AM, Moustafa AA. Dose-dependent neuroprotective effect of caffeine on a rotenone-induced rat model of parkinsonism: a histological study. Neurosci Lett. 2016;623:63\u201370. doi: 10.1016/j.neulet.2016.04.057.", "ArticleIdList": ["10.1016/j.neulet.2016.04.057", "27132082"]}, {"Citation": "Sonsalla PK, Wong L-Y, Harris SL, Richardson JR, Khobahy I, Li W, et al. Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease. Exp Neurol. 2012;234(2):482\u2013487. doi: 10.1016/j.expneurol.2012.01.022.", "ArticleIdList": ["10.1016/j.expneurol.2012.01.022", "PMC3303955", "22309831"]}, {"Citation": "Alasmari F. Caffeine induces neurobehavioral effects through modulating neurotransmitters. Saudi Pharmaceutical J. 2020;28(4):445\u2013451. doi: 10.1016/j.jsps.2020.02.005.", "ArticleIdList": ["10.1016/j.jsps.2020.02.005", "PMC7132598", "32273803"]}, {"Citation": "Kim HG, Ju MS, Shim JS, Kim MC, Lee S-H, Huh Y, et al. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models. Br J Nutr. 2010;104(1):8\u201316. doi: 10.1017/S0007114510000218.", "ArticleIdList": ["10.1017/S0007114510000218", "20187987"]}, {"Citation": "Hong M, Lu M, Qian Y, Wei L, Zhang Y, Pan X, et al. A 90-day sub-chronic Oral toxicity assessment of mulberry extract in Sprague Dawley rats. INQUIRY: The Journal of Health Care Organization, Provision, and Financing. 2021;58:00469580211056044.", "ArticleIdList": ["PMC8613892", "34812659"]}, {"Citation": "Govindan S, Amirthalingam M, Duraisamy K, Govindhan T, Sundararaj N, Palanisamy S. Phytochemicals-induced hormesis protects Caenorhabditis elegans against \u03b1-synuclein protein aggregation and stress through modulating HSF-1 and SKN-1/Nrf2 signaling pathways. Biomed Pharmacother. 2018;102:812\u2013822. doi: 10.1016/j.biopha.2018.03.128.", "ArticleIdList": ["10.1016/j.biopha.2018.03.128", "29605769"]}, {"Citation": "Mengdi X, Wenqing C, Haibo D, Xiaoqing W, Li Y, Yuchen K, et al. Cadmium-induced hormesis effect in medicinal herbs improves the efficiency of safe utilization for low cadmium-contaminated farmland soil. Ecotoxicol Environ Saf. 2021;225:112724. doi: 10.1016/j.ecoenv.2021.112724.", "ArticleIdList": ["10.1016/j.ecoenv.2021.112724", "34509162"]}, {"Citation": "Zhang Y-L, Liu Y, Kang X-P, Dou C-Y, Zhuo R-G, Huang S-Q, et al. Ginsenoside Rb1 confers neuroprotection via promotion of glutamate transporters in a mouse model of Parkinson's disease. Neuropharmacology. 2018;131:223\u2013237. doi: 10.1016/j.neuropharm.2017.12.012.", "ArticleIdList": ["10.1016/j.neuropharm.2017.12.012", "29241654"]}, {"Citation": "El-Horany HE, El-latif RNA, ElBatsh MM, Emam MN. Ameliorative effect of quercetin on neurochemical and behavioral deficits in rotenone rat model of Parkinson's disease: modulating autophagy (quercetin on experimental Parkinson's disease) J Biochem Mol Toxicol. 2016;30(7):360\u2013369. doi: 10.1002/jbt.21821.", "ArticleIdList": ["10.1002/jbt.21821", "27252111"]}, {"Citation": "Ay M, Luo J, Langley M, Jin H, Anantharam V, Kanthasamy A, et al. Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's disease. J Neurochem. 2017;141(5):766\u2013782. doi: 10.1111/jnc.14033.", "ArticleIdList": ["10.1111/jnc.14033", "PMC5643047", "28376279"]}, {"Citation": "Chen R, Lin J, Hong J, Han D, Zhang AD, Lan R, et al. Potential toxicity of quercetin: the repression of mitochondrial copy number via decreased POLG expression and excessive TFAM expression in irradiated murine bone marrow. Toxicol Rep. 2014;1:450\u2013458. doi: 10.1016/j.toxrep.2014.07.014.", "ArticleIdList": ["10.1016/j.toxrep.2014.07.014", "PMC5598249", "28962259"]}, {"Citation": "Chirumbolo S. Hormesis, resveratrol and plant-derived polyphenols: some comments. Hum Exp Toxicol. 2011;30(12):2027\u20132030. doi: 10.1177/0960327111408153.", "ArticleIdList": ["10.1177/0960327111408153", "21558146"]}, {"Citation": "Brunetti G, Di Rosa G, Scuto M, Leri M, Stefani M, Schmitz-Linneweber C, et al. Healthspan maintenance and prevention of Parkinson\u2019s-like phenotypes with Hydroxytyrosol and Oleuropein Aglycone in C. elegans. Int J Mol Sci. 2020;21(7):2588. doi: 10.3390/ijms21072588.", "ArticleIdList": ["10.3390/ijms21072588", "PMC7178172", "32276415"]}, {"Citation": "Kouka P, Tekos F, Papoutsaki Z, Stathopoulos P, Halabalaki M, Tsantarliotou M, et al. Olive oil with high polyphenolic content induces both beneficial and harmful alterations on rat redox status depending on the tissue. Toxicol Rep. 2020;7:421\u2013432. doi: 10.1016/j.toxrep.2020.02.007.", "ArticleIdList": ["10.1016/j.toxrep.2020.02.007", "PMC7052070", "32140426"]}, {"Citation": "Martucci M, Ostan R, Biondi F, Bellavista E, Fabbri C, Bertarelli C, et al. Mediterranean diet and inflammaging within the hormesis paradigm. Nutr Rev. 2017;75(6):442\u2013455. doi: 10.1093/nutrit/nux013.", "ArticleIdList": ["10.1093/nutrit/nux013", "PMC5914347", "28595318"]}, {"Citation": "Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fern\u00e1ndez-Ruiz J. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. Neurobiol Dis. 2005;19(1-2):96\u2013107. doi: 10.1016/j.nbd.2004.11.009.", "ArticleIdList": ["10.1016/j.nbd.2004.11.009", "15837565"]}, {"Citation": "Liu H, Mao P, Wang J, Wang T, Xie C-H. Allicin protects PC12 cells against 6-OHDA-induced oxidative stress and mitochondrial dysfunction via regulating mitochondrial dynamics. Cell Physiol Biochem. 2015;36(3):966\u2013979. doi: 10.1159/000430271.", "ArticleIdList": ["10.1159/000430271", "26087780"]}, {"Citation": "Sharma N, Nehru B. Curcumin affords neuroprotection and inhibits \u03b1-synuclein aggregation in lipopolysaccharide-induced Parkinson\u2019s disease model. Inflammopharmacology. 2018;26(2):349\u2013360. doi: 10.1007/s10787-017-0402-8.", "ArticleIdList": ["10.1007/s10787-017-0402-8", "29027056"]}, {"Citation": "Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res. 2005;39(10):1119\u20131125. doi: 10.1080/10715760500233113.", "ArticleIdList": ["10.1080/10715760500233113", "16298737"]}, {"Citation": "Parlakpinar H, Ozhan O, Ermis N, Vardi N, Cigremis Y, Tanriverdi LH, et al. Acute and subacute effects of low versus high doses of standardized panax ginseng extract on the heart: an experimental study. Cardiovasc Toxicol. 2019;19(4):306\u2013320. doi: 10.1007/s12012-019-09512-1.", "ArticleIdList": ["10.1007/s12012-019-09512-1", "30900193"]}, {"Citation": "Zhang C, Li C, Chen S, Li Z, Jia X, Wang K, et al. Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 pathways. Redox Biol. 2017;11:1\u201311. doi: 10.1016/j.redox.2016.10.019.", "ArticleIdList": ["10.1016/j.redox.2016.10.019", "PMC5107737", "27835779"]}, {"Citation": "Elmazoglu Z, Yar Saglam AS, Sonmez C, Karasu C. Luteolin protects microglia against rotenone-induced toxicity in a hormetic manner through targeting oxidative stress response, genes associated with Parkinson\u2019s disease and inflammatory pathways. Drug Chem Toxicol. 2020;43(1):96\u2013103. doi: 10.1080/01480545.2018.1504961.", "ArticleIdList": ["10.1080/01480545.2018.1504961", "30207190"]}, {"Citation": "Calabrese EJ, Kozumbo WJ. The phytoprotective agent sulforaphane prevents inflammatory degenerative diseases and age-related pathologies via Nrf2-mediated hormesis. Pharmacol Res. 2020;105283.", "ArticleIdList": ["33160067"]}, {"Citation": "Kumar P, Kalonia H, Kumar A. Huntington\u2019s disease: pathogenesis to animal models. Pharmacol Rep. 2010;62(1):1\u201314. doi: 10.1016/S1734-1140(10)70238-3.", "ArticleIdList": ["10.1016/S1734-1140(10)70238-3", "20360611"]}, {"Citation": "Gao Y, Chu S-f, Li J-p, Zhang Z, J-q Y, Z-l W, et al. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease. Acta Pharmacol Sin. 2015;36(3):311\u2013322. doi: 10.1038/aps.2014.107.", "ArticleIdList": ["10.1038/aps.2014.107", "PMC4349920", "25640478"]}, {"Citation": "Jang M, Lee MJ, Kim CS, Cho I-H. Korean red ginseng extract attenuates 3-nitropropionic acid-induced Huntington\u2019s-like symptoms. Evid Based Complement Alternat Med. 2013;2013.", "ArticleIdList": ["PMC3568869", "23431333"]}, {"Citation": "Maher P, Dargusch R, Bodai L, Gerard PE, Purcell JM, Marsh JL. ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. Hum Mol Genet. 2011;20(2):261\u2013270. doi: 10.1093/hmg/ddq460.", "ArticleIdList": ["10.1093/hmg/ddq460", "PMC3005900", "20952447"]}, {"Citation": "Shivasharan B, Nagakannan P, Thippeswamy BS, Veerapur VP, Bansal P, Unnikrishnan MK. Protective effect of Calendula officinalis Linn. Flowers against 3-nitropropionic acid induced experimental Huntington\u2019s disease in rats. Drug Chem Toxicol. 2013;36(4):466\u2013473. doi: 10.3109/01480545.2013.776583.", "ArticleIdList": ["10.3109/01480545.2013.776583", "23590827"]}, {"Citation": "Lagarto A, Bueno V, Guerra I, Vald\u00e9s O, Vega Y, Torres L. Acute and subchronic oral toxicities of Calendula officinalis extract in Wistar rats. Exp Toxicol Pathol. 2011;63(4):387\u2013391. doi: 10.1016/j.etp.2010.02.015.", "ArticleIdList": ["10.1016/j.etp.2010.02.015", "20335011"]}, {"Citation": "Ramachandran S, Thangarajan S. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington\u2019s disease-like symptoms in wistar rats. Chem Biol Interact. 2016;256:25\u201336. doi: 10.1016/j.cbi.2016.05.020.", "ArticleIdList": ["10.1016/j.cbi.2016.05.020", "27206696"]}, {"Citation": "Badary OA, Al-Shabanah OA, Nagi MN, Al-Bekairi AM, Elmazar M. Acute and subchronic toxicity of thymoquinone in mice. Drug Dev Res. 1998;44(2-3):56\u201361. doi: 10.1002/(SICI)1098-2299(199806/07)44:2/3<56::AID-DDR2>3.0.CO;2-9.", "ArticleIdList": ["10.1002/(SICI)1098-2299(199806/07)44:2/3<56::AID-DDR2>3.0.CO;2-9"]}, {"Citation": "Calabrese V, Giordano J, Ruggieri M, Berritta D, Trovato A, Ontario M, et al. Hormesis, cellular stress response, and redox homeostasis in autism spectrum disorders. J Neurosci Res. 2016;94(12):1488\u20131498. doi: 10.1002/jnr.23893.", "ArticleIdList": ["10.1002/jnr.23893", "27642708"]}, {"Citation": "Zhang Y, Ahn Y-H, Benjamin IJ, Honda T, Hicks RJ, Calabrese V, et al. HSF1-dependent upregulation of Hsp70 by sulfhydryl-reactive inducers of the KEAP1/NRF2/ARE pathway. Chem Biol. 2011;18(11):1355\u20131361. doi: 10.1016/j.chembiol.2011.09.008.", "ArticleIdList": ["10.1016/j.chembiol.2011.09.008", "PMC3302153", "22118669"]}, {"Citation": "Liu H, Talalay P, Fahey W, J. Biomarker-guided strategy for treatment of autism spectrum disorder (ASD) CNS & Neurological Disorders-Drug Targets formerly current drug targets-CNS & Neurol Dis Ther. 2016;15(5):602\u2013613.", "ArticleIdList": ["27071792"]}, {"Citation": "Singh K, Connors SL, Macklin EA, Smith KD, Fahey JW, Talalay P, et al. Sulforaphane treatment of autism spectrum disorder (ASD) Proc Natl Acad Sci. 2014;111(43):15550\u201315555. doi: 10.1073/pnas.1416940111.", "ArticleIdList": ["10.1073/pnas.1416940111", "PMC4217462", "25313065"]}, {"Citation": "Momtazmanesh S, Amirimoghaddam-Yazdi Z, Moghaddam HS, Mohammadi MR, Akhondzadeh S. Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: a randomized, double-blind, placebo-controlled clinical trial. Psychiatry Clin Neurosci. 2020;74(7):398\u2013405. doi: 10.1111/pcn.13016.", "ArticleIdList": ["10.1111/pcn.13016", "32347624"]}, {"Citation": "Zimmerman A, Diggins E, Connors S, Singh K. Sulforaphane treatment of children with autism Spectrum disorder (ASD) \u2013 a Progress report (N1.002) Neurology. 2018;90(15 Supplement):N1.002."}, {"Citation": "Evans S, Fuller D. Initial outcomes from an autism treatment demonstration. Clinical and Medical Investigations. 2016;1."}, {"Citation": "Bent S, Lawton B, Warren T, Widjaja F, Dang K, Fahey JW, et al. Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli. Molecular autism. 2018;9(1):1\u201312. doi: 10.1186/s13229-018-0218-4.", "ArticleIdList": ["10.1186/s13229-018-0218-4", "PMC5975568", "29854372"]}, {"Citation": "Nadeem A, Ahmad SF, Al-Harbi NO, Attia SM, Bakheet SA, Ibrahim KE, et al. Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+ tf/J mice. Behav Brain Res. 2019;364:213\u2013224. doi: 10.1016/j.bbr.2019.02.031.", "ArticleIdList": ["10.1016/j.bbr.2019.02.031", "30790585"]}, {"Citation": "Zimmerman AW, Singh K, Connors SL, Liu H, Panjwani AA, Lee L-C, et al. Randomized controlled trial of sulforaphane and metabolite discovery in children with autism Spectrum disorder. Molecular autism. 2021;12(1):1\u201322. doi: 10.1186/s13229-020-00405-7.", "ArticleIdList": ["10.1186/s13229-020-00405-7", "PMC8146218", "34034808"]}, {"Citation": "Liu H, Zimmerman AW, Singh K, Connors SL, Diggins E, Stephenson KK, et al. Biomarker exploration in human peripheral blood mononuclear cells for monitoring sulforaphane treatment responses in autism spectrum disorder. Sci Rep. 2020;10(1):1\u201311. doi: 10.1038/s41598-019-56847-4.", "ArticleIdList": ["10.1038/s41598-019-56847-4", "PMC7118069", "32242086"]}, {"Citation": "Lynch R, Diggins EL, Connors SL, Zimmerman AW, Singh K, Liu H, et al. Sulforaphane from broccoli reduces symptoms of autism: a follow-up case series from a randomized double-blind study. Global Adv Health Med. 2017;6:2164957X17735826. doi: 10.1177/2164957X17735826.", "ArticleIdList": ["10.1177/2164957X17735826", "PMC5672987", "29147630"]}, {"Citation": "Calabrese EJ. Hormesis and medicine. Br J Clin Pharmacol. 2008;66(5):594\u2013617.", "ArticleIdList": ["PMC2661975", "18662293"]}, {"Citation": "Calabrese EJ. Alzheimer's disease drugs: an application of the hormetic dose-response model. Crit Rev Toxicol. 2008;38(5):419\u2013451. doi: 10.1080/10408440802003991.", "ArticleIdList": ["10.1080/10408440802003991", "18568864"]}, {"Citation": "Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society. 2001;16(3):507\u2013510. doi: 10.1002/mds.1099.", "ArticleIdList": ["10.1002/mds.1099", "11391746"]}, {"Citation": "Quattrone A, Zappia M, Aguglia U, Branca D, Colao R, Montesanti R, et al. The subacute levodopa test for evaluating long-duration response in Parkinson's disease. Ann Neurol. 1995;38(3):389\u2013395. doi: 10.1002/ana.410380308.", "ArticleIdList": ["10.1002/ana.410380308", "7668824"]}, {"Citation": "Zappia M, Oliveri R, Bosco D, Nicoletti G, Branca D, Caracciolo M, et al. The long-duration response to L-dopa in the treatment of early PD. Neurology. 2000;54(10):1910\u20131915. doi: 10.1212/WNL.54.10.1910.", "ArticleIdList": ["10.1212/WNL.54.10.1910", "10822428"]}, {"Citation": "Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci. 2001;24(1):167\u2013202. doi: 10.1146/annurev.neuro.24.1.167.", "ArticleIdList": ["10.1146/annurev.neuro.24.1.167", "11283309"]}, {"Citation": "Chen T, Hou R, Xu S, Wu C. Donepezil regulates 1-methyl-4-phenylpyridinium-induced microglial polarization in Parkinson\u2019s disease. ACS Chem Neurosci. 2015;6(10):1708\u20131714. doi: 10.1021/acschemneuro.5b00026.", "ArticleIdList": ["10.1021/acschemneuro.5b00026", "26114860"]}, {"Citation": "Pisanu A, Lecca D, Mulas G, Wardas J, Simbula G, Spiga S, et al. Dynamic changes in pro-and anti-inflammatory cytokines in microglia after PPAR-\u03b3 agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease. Neurobiol Dis. 2014;71:280\u2013291. doi: 10.1016/j.nbd.2014.08.011.", "ArticleIdList": ["10.1016/j.nbd.2014.08.011", "25134730"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "3"}, {"Year": "2022", "Month": "7", "Day": "24"}, {"Year": "2022", "Month": "8", "Day": "11", "Hour": "23", "Minute": "38"}, {"Year": "2022", "Month": "8", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "8", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["35953850", "PMC9367062", "10.1186/s12979-022-00292-x", "10.1186/s12979-022-00292-x"]}}], "PubmedBookArticle": []}